Sanofi (United States) - Academic Profile

Publications

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz , Philippe Gabríel Steg , Michael Szarek +19 more

Among patients who had a previous acute coronary syndrome and who were receiving high-intensity statin therapy, the risk of recurrent ischemic cardiovascular events was lower am...

2018 New England Journal of Medicine 3201 citations

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon , Derek Wallace , Chukiat Sirivichayakul +13 more

2012 The Lancet 798 citations

Affiliated Researchers

Institution Info

Type: company
Country: US
Publications: 2
Citations: 3,999

External Links

Identifiers

ROR: https://ror.org/027vj4x92

Publications

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Affiliated Researchers

Nadia Tornieporth

Jay M. Edelberg

Angèle Moryusef

Jean‐François Tamby

Institution Info

External Links

Identifiers